Anemia
Conference Coverage
Primary care needs pile up for sickle cell patients
BETHESDA, MD. – With people often surviving into middle age with SCD, physicians need to keep in mind the routine complications of aging in these...
Conference Coverage
Sickle cell disease gene therapy seen advancing
BETHESDA, MD. – NIH conference highlights experimental gene therapies for SCD and thalassemia, with further updates on this work slated for ASH’s...
News
FDA approves DNA-based blood type test
This is the first molecular-based test for red blood cell types to report genotypes in its results.
From the Journals
Crizanlizumab relieves sickle cell crises across subgroups
The post hoc analysis of the SUSTAIN trial showed a significant decrease in painful vaso-occlusive crises.
Feature
In Ghana, SCD research is meeting patients on home turf
The West African nation stands ready to solve the geographic mismatch between research capacity and patient population.
From the Journals
Phase 3 results shed light on L-glutamine use in SCD
L-glutamine is not only an alternative to hydroxyurea but an additive therapy for patients with suboptimal response, the researchers said.
Conference Coverage
Hematocrit improvement with SGLT2 inhibitor: Not just a diuretic effect?
BOSTON – New study explores mechanisms beyond those already known or suspected.
News
FDA approves epoetin alfa biosimilar to treat anemia
This is the first product approved as biosimilar to epoetin alfa.
Conference Coverage
IV superior to oral treatment for iron deficiency during pregnancy
AUSTIN, TEX. – Improving anemia treatment beyond the standard oral supplements could have a large effect on decreasing pregnancy complications.
From the Journals
Meta-analysis finds no link between stroke and sickle cell trait
Neither crude stroke incidence rates nor regression analysis indicated a link between sickle cell trait in African Americans and stroke.
From the Journals
Sotatercept promising for treatment of anemia in MDS
The phase 2 trial included patients who did not respond to erythropoiesis-stimulating agents.